The cluster is too small relative to market cap to be a standalone signal. Monitor for any upcoming earnings or pipeline catalysts that might have prompted the selling, but no immediate action is warranted.
TAK drugs
TAK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 13 $17.39entry
- T+1 · 3mo ago +1.38%α +1.58% · $17.63
- T+5 · 3mo ago +4.26%α +6.22% · $18.13
- T+20 · 2mo ago +5.00%α +6.75% · $18.26
- T+60 · 11d ago +20.87%α +26.35% · $21.02
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of 13 Takeda insiders, including the CEO and President of R&D, sold a total of $8.64M in open-market sales on August 10, 2026. While the dollar amount is only ~0.016% of the $55.2B market cap (trivial), the breadth of the selling, covering the CEO, C-suite, and multiple business unit presidents on a single day, is notable. Per the academic literature, cluster sells are weak predictors, and the proportionality is below the materiality threshold, making this a neutral event with low impact.
Key Financial Metrics
Key Facts
- 13 insiders sold shares on August 10, 2026, totaling $8.64M.
- CEO Julie So-Young Kim sold $1.52M; President of R&D Andrew Plump sold $2.83M.
- Total sales represent ~0.016% of Takeda's $55.2B market cap.
- No insider purchases were reported in the cluster window.
Financial Impact
$8.64M in insider sales, trivial relative to $55.2B market cap
Risk Factors
- Insider selling could indicate a lack of confidence in near-term prospects, though the dollar amount is immaterial.
- No purchases to offset the selling signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TAK-1786611740779 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Viewing Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers